Bacillus Subtilis Spores As Delivery System for Nasal Plasmodium Falciparum Circumsporozoite Surface Protein Immunization in a Murine Model

Malaria remains a widespread public health problem in tropical and subtropical regions around the world, and there is still no vaccine available for full protection. In recent years, it has been observed that spores of Bacillus subtillis can act as a vaccine carrier and adjuvant, promoting an elevated humoral response after co-administration with antigens either coupled or integrated to their surface. In our study, B. subtillis spores from the KO7 strain were used to couple the recombinant CSP protein of P. falciparum (rPfCSP), and the nasal humoral-induced immune response in Balb/C mice was evaluated. Our results demonstrate that the spores coupled to rPfCSP increase the immunogenicity of the antigen, which induces high levels of serum IgG, and with balanced Th1/Th2 immune response, being detected antibodies in serum samples for 250 days. Therefore, the use of B. subtilis spores appears to be promising for use as an adjuvant in a vaccine formulation.

Citing Articles

Bacillus subtilis surface display technology: applications in bioprocessing and sustainable manufacturing.

Bahrulolum H, Ahmadian G Biotechnol Biofuels Bioprod. 2025; 18(1):34.

PMID: 40089785 DOI: 10.1186/s13068-025-02635-4.

Important role of Bacillus subtilis as a probiotic and vaccine carrier in animal health maintenance.

Yuan C, Ji X, Zhang Y, Liu X, Ding L, Li J World J Microbiol Biotechnol. 2024; 40(9):268.

PMID: 39007987 DOI: 10.1007/s11274-024-04065-0.

Effect of Bacillus subtilis and Bacillus coagulans spores on induced allergic contact dermatitis in dogs.

Khosravi M, Avizeh R, Zayerzadeh A, Gharibi D, Razijalali M Vet Med Sci. 2024; 10(3):e1410.

PMID: 38501344 PMC: 10949178. DOI: 10.1002/vms3.1410.

Bacterial Spore-Based Delivery System: 20 Years of a Versatile Approach for Innovative Vaccines.

Isticato R Biomolecules. 2023; 13(6).

PMID: 37371527 PMC: 10296236. DOI: 10.3390/biom13060947.

Humoral Immune Responses to Circumsporozoite Protein (Pfcsp) Induced by the RTS, S Vaccine - Current Update.

Ngulube P Infect Drug Resist. 2023; 16:2147-2157.

PMID: 37077252 PMC: 10106824. DOI: 10.2147/IDR.S401247.

References

Dai X, Liu M, Pan K, Yang J . Surface display of OmpC of Salmonella serovar Pullorum on Bacillus subtilis spores. PLoS One. 2018; 13(1):e0191627. PMC: 5785212. DOI: 10.1371/journal.pone.0191627. View

Amuguni J, Lee S, Kerstein K, Brown D, Belitsky B, Herrmann J . Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice. Vaccine. 2011; 29(29-30):4778-84. DOI: 10.1016/j.vaccine.2011.04.083. View

Noe A, Espinosa D, Li X, Coelho-Dos-Reis J, Funakoshi R, Giardina S . A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate. PLoS One. 2014; 9(9):e107764. PMC: 4172688. DOI: 10.1371/journal.pone.0107764. View

Kurtovic L, Boyle M, Opi D, Kennedy A, Tham W, Reiling L . Complement in malaria immunity and vaccines. Immunol Rev. 2019; 293(1):38-56. PMC: 6972673. DOI: 10.1111/imr.12802. View

Wang Y, Wang J, Zhou M, Liu P, Zhang E, Li Y . Mucosal and systemic immune responses induced by intranasal immunization of recombinant Bacillus subtilis expressing the P97R1, P46 antigens of Mycoplasma hyopneumoniae. Biosci Rep. 2019; 39(10). PMC: 6822509. DOI: 10.1042/BSR20191126. View

Plassmeyer M, Reiter K, Shimp Jr R, Kotova S, Smith P, Hurt D . Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate. J Biol Chem. 2009; 284(39):26951-63. PMC: 2785382. DOI: 10.1074/jbc.M109.013706. View

de Souza R, Batista M, Luiz W, Marques Cavalcante R, Amorim J, Bizerra R . Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLoS One. 2014; 9(1):e87454. PMC: 3903701. DOI: 10.1371/journal.pone.0087454. View

Barnes A, Cerovic V, Hobson P, Klavinskis L . Bacillus subtilis spores: a novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen. Eur J Immunol. 2007; 37(6):1538-47. DOI: 10.1002/eji.200636875. View

Jelinkova L, Jhun H, Eaton A, Petrovsky N, Zavala F, Chackerian B . An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein. NPJ Vaccines. 2021; 6(1):13. PMC: 7820318. DOI: 10.1038/s41541-020-00274-4. View

10.

Datoo M, Natama M, Some A, Traore O, Rouamba T, Bellamy D . Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet. 2021; 397(10287):1809-1818. PMC: 8121760. DOI: 10.1016/S0140-6736(21)00943-0. View

11.

Heide J, Vaughan K, Sette A, Jacobs T, Schulze Zur Wiesch J . Comprehensive Review of Human -Specific CD8+ T Cell Epitopes. Front Immunol. 2019; 10:397. PMC: 6438266. DOI: 10.3389/fimmu.2019.00397. View

12.

Song M, Hong H, Huang J, Colenutt C, Khang D, Nguyen T . Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. Vaccine. 2012; 30(22):3266-77. DOI: 10.1016/j.vaccine.2012.03.016. View

13.

Santos F, Mazzoli A, Maia A, Saggese A, Isticato R, Leite F . A probiotic treatment increases the immune response induced by the nasal delivery of spore-adsorbed TTFC. Microb Cell Fact. 2020; 19(1):42. PMC: 7029466. DOI: 10.1186/s12934-020-01308-1. View

14.

Lee S, Belitsky B, Brinker J, Kerstein K, Brown D, Clements J . Development of a Bacillus subtilis-based rotavirus vaccine. Clin Vaccine Immunol. 2010; 17(11):1647-55. PMC: 2976104. DOI: 10.1128/CVI.00135-10. View

15.

Mauriello E, Duc L, Isticato R, Cangiano G, Hong H, De Felice M . Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner. Vaccine. 2004; 22(9-10):1177-87. DOI: 10.1016/j.vaccine.2003.09.031. View

16.

Oyen D, Torres J, Wille-Reece U, Ockenhouse C, Emerling D, Glanville J . Structural basis for antibody recognition of the NANP repeats in circumsporozoite protein. Proc Natl Acad Sci U S A. 2017; 114(48):E10438-E10445. PMC: 5715787. DOI: 10.1073/pnas.1715812114. View

17.

Dobano C, Santano R, Vidal M, Jimenez A, Jairoce C, Ubillos I . Differential Patterns of IgG Subclass Responses to Antigens in Relation to Malaria Protection and RTS,S Vaccination. Front Immunol. 2019; 10:439. PMC: 6428712. DOI: 10.3389/fimmu.2019.00439. View

18.

Zhou Z, Gong S, Li X, Yang Y, Guan R, Zhou S . Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. J Med Microbiol. 2014; 64(Pt 1):104-110. DOI: 10.1099/jmm.0.076430-0. View

19.

Huang J, Hong H, Van Tong H, Hoang T, Brisson A, Cutting S . Mucosal delivery of antigens using adsorption to bacterial spores. Vaccine. 2009; 28(4):1021-30. DOI: 10.1016/j.vaccine.2009.10.127. View

20.

Stoute J, Slaoui M, Heppner D, Momin P, Kester K, Desmons P . A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med. 1997; 336(2):86-91. DOI: 10.1056/NEJM199701093360202. View